Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto Awards RNAi Research Grant to Iowa State Investigator

Premium

Monsanto this week announced that it has awarded an Iowa State University researcher a grant to develop an RNAi-based approach to control corn rootworm as part of a broader grant program supporting research into ways of controlling the agricultural pest.

The grants provide as much as $250,000 a year in funding for up to three years.

According to the company, Iowa State University professor Bryony Bonning was awarded the grant to identify viruses of the corn rootworm, assess the potential for using viruses to control the insect, and develop a vector for RNAi-induced gene silencing in it.

Monsanto has a number of internal efforts ongoing to apply RNAi to controlling corn rootworm, including one that could be ready for commercialization by 2016 (GSN 1/17/2013).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.